§ BIOTECHNOLOGY
USD · BiotechnologyKYMR
KYMERA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 2.05
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
161 increased/new, 81 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 3.89 | EPS (TTM) | -3.57 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 11.7M | 0.1% | +31% |
| BAKER BROS. ADVISORS LP | 8.7M | 4.1% | ±0% |
| Avoro Capital Advisors LLC | 7.5M | 6.1% | n/a |
| BVF INC/IL | 5.5M | 14.6% | ±0% |
| BlackRock, Inc. | 5.1M | 0.0% | +1% |
| Atlas Venture Life Science Advisors, LLC | 4.6M | 48.3% | −2% |
◇ AC INTELLIGENCE
Top institutional owners for KYMR as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER98.5% · 0 holders
OTHER1.0% · 182 holders
QUALITY / COMPOUNDER0.3% · 22 holders
PASSIVE / INDEX0.1% · 10 holders
DEALER / BANK0.1% · 23 holders
INCOME / DEFENSIVE0.0% · 16 holders
TACTICAL / MACRO0.0% · 2 holders
GROWTH / MOMENTUM0.0% · 1 holder
SYSTEMATIC / QUANT0.0% · 4 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for KYMR in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention KYMR yet.